SIMPLE METHOD TO CALCULATE THE CONFIDENCE INTERVAL OF A STANDARDIZED MORTALITY RATIO (SMR)
1990/02/01 by K. ULM, K. Ulm · 31 citations
Mathematics · Decision Sciences · #Statistical Methods and Bayesian Inference #Advanced Causal Inference Techniques #Optimal Experimental Design Methods
paper · doi:10.1093/oxfordjournals.aje.a115507
Abstract
In analyzing standardized mortality ratios (SMRs), it is of interest to calculate a confidence interval for the true SMR. The exact limits of a specific interval can be obtained by means of the Poisson distribution either within an iterative procedure or by one of the tables. The limits can be approximated in using one of various shortcut methods. In this paper, a method is described for calculating the exact limits in a simple and easy way. The method is based on the link between the chi 2 distribution and the Poisson distribution. Only a table of the chi 2 distribution is necessary.
Cited by
- Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008—A Swedish population‐based study
- A decadally-resolved paleohurricane record archived in the late Holocene sediments of a Florida sinkhole
- Mortality differences between self-employed and paid employees: a 5-year follow-up study of the working population in Sweden
- Continuing rise of Type 2 diabetes incidence in children and young people in the UK
- Albuminuria is associated with increased risk of dementia, independent of eGFR: The SCREAM project
- L‐Relationship between uncertainty and average seizure frequency in clinical trials of antiseizure medications
- Nurse staffing and postsurgical adverse events: an analysis of administrative data from a sample of U.S. hospitals, 1990-1996. [europepmc]
- Prognosis in patients achieving ≥10 METS on exercise stress testing: was SPECT imaging useful? [europepmc]
- Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. [europepmc]
- Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes. [europepmc]
- Verbal autopsy-based cause-specific mortality trends in rural KwaZulu-Natal, South Africa, 2000-2009. [europepmc]
- A longitudinal investigation of mortality in anorexia nervosa and bulimia nervosa. [europepmc]
- Geographical variation in Plasmodium vivax relapse. [europepmc]
- Mortality, causes of death, and health status among methamphetamine users. [europepmc]
- The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. [europepmc]
- A Comparison of Recruitment Methods for an mHealth Intervention Targeting Mothers: Lessons from the Growing Healthy Program. [europepmc]
- Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. [europepmc]
- Cardiovascular Disease Burden and Socioeconomic Correlates: Findings From the Jackson Heart Study. [europepmc]
- Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study. [europepmc]
- The plateau of human mortality: Demography of longevity pioneers. [europepmc]
- Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review. [europepmc]
- Whole-genome sequences of Malawi cichlids reveal multiple radiations interconnected by gene flow. [europepmc]
- Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer. [europepmc]
- Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study. [europepmc]
- Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. [europepmc]
- Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years. [europepmc]
- Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. [europepmc]
- Attributable Mortality of Ventilator-associated Pneumonia Among Patients with COVID-19. [europepmc]
- Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries. [europepmc]
- Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study. [europepmc]
- Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT register. [europepmc]
Related